Today: 1 May 2026
TSX logs best month since 2020, then slips Friday: what Toronto Stock Exchange investors watch next week
28 February 2026
2 mins read

TSX logs best month since 2020, then slips Friday: what Toronto Stock Exchange investors watch next week

Toronto, February 28, 2026, 01:44 (ET) — The market has closed.

The S&P/TSX Composite Index wrapped up the week of Feb. 27 at 34,339.99, slipping around 0.5% on Friday. Still, that left the index up about 1.5% compared to the previous week’s finish. February locked in a gain of nearly 7.6%—the best monthly run seen since November 2020.

The late-month slide took a bite out of the market leaders. Financials dropped 1.9%, tech names were off 2.5% on Friday, snapping the index’s three-day record streak—even as gains in oil and gold managed to keep energy and materials in positive territory. Angelo Kourkafas, senior global investment strategist at Edward Jones, pointed out that concerns about artificial intelligence are starting to impact financial stocks too, with “private credit issues”—that is, loans beyond the banking sector—adding to the pressure, while capital shifts back to materials and energy. Reuters

The outlook for Canada soured heading into March. Statscan data showed the economy shrank at a 0.6% annualized pace in the fourth quarter, with 2025 growth easing back to 1.7% as firms cut inventories instead of stepping up production. “The details … were much firmer than the headline suggests,” said Doug Porter, BMO Capital Markets’ chief economist. Still, he noted, the economy was “hardly thriving” given tariff and trade uncertainty. Reuters

Bay Street doubled down on its old standbys—banks and resources—earlier this week, and that classic strategy delivered, at least for a while. On Thursday, the TSX closed at yet another record, climbing 1.1% to finish at 34,501.96. TD Bank and CIBC both beat profit expectations; Enerflex surged 17.7% after reporting its quarterly numbers. “Bank stocks continue to knock the lights out,” said Allan Small, investment adviser at iA Private Wealth. Reuters

AI volatility isn’t confined to Toronto. U.S. investors have been bouncing between stocks seen as likely AI winners and those facing disruption, trying to gauge just how much the technology will reshape business models. Nerves over AI have started to ripple through software-heavy sectors elsewhere, too. “There continues to be this … back and forth about who might be the victim,” said Kristina Hooper, chief market strategist at Man Group. Next week’s U.S. jobs report is shaping up as a major test for rate bets. Reuters

Still, risks abound. Oil-driven rallies may evaporate fast should supply fears recede or Middle East strains calm down, and gold stocks aren’t immune if safe-haven demand tapers off. A deeper Canadian slowdown—more drag in hiring, weaker consumer spending—could spell higher credit losses for banks, all while investors keep a close eye on potential cracks in non-bank lending.

Canadian markets are back in action Monday, but there’s not much on the data front until fourth-quarter labour productivity and unit labour costs arrive March 4. Those figures tend to influence investor views on wage trends and inflation, which in turn can sway rate expectations.

There are still two key dates ahead in March: the February labour force survey drops March 13, followed by the Bank of Canada’s policy-rate decision set for March 18. Friday’s GDP pullback has already rattled investors. If the jobs numbers show weakness, rate-sensitive names on the TSX could take another hit.

The first major event for global markets comes with February’s U.S. Employment Situation report, set for release at 8:30 a.m. ET on March 6. These numbers have the power to jolt bond yields—and that usually spills over to impact the mood in TSX banks, tech, and commodity stocks.

Stock Market Today

  • Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK
    May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines and capital strategies amid challenging market conditions.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 12:18 AM EDT Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Alphabet GOOG stock price rises on Meta AI chip deal, then slips after hours amid new Google ads probe
Previous Story

Alphabet GOOG stock price rises on Meta AI chip deal, then slips after hours amid new Google ads probe

Warsaw Stock Exchange recap: WIG20 ends last week higher, but PZU and Allegro headlines loom
Next Story

Warsaw Stock Exchange recap: WIG20 ends last week higher, but PZU and Allegro headlines loom

Go toTop